US 2010/0303856 A1Published application

Intergenic regions as insertion sites in the genome of modified vaccinia virus ankara (mva)

AssigneeBavarian Nordic A/S

InventorsPaul Howley, Sonja Leyrer

Life of this patent

Estimating the term…

Abstract

The present invention relates to novel insertion sites useful for the integration of exogenous sequences into the Modified Vaccinia Ankara (MVA) virus genome. The present invention further provides plasmid vectors to insert exogenous DNA into the genome of MVA. Furthermore, the present invention provides recombinant MVA comprising an exogenous DNA sequence inserted into said new insertion site as medicine or vaccine.

Claims32

Dependent claims

1-42. (canceled)

Dependencies are inferred from the claim text.

Facts

Application: 12/468,127Filed 19 May 2009
Priority: DK PA 2002 0075216 May 2002
Published: 2 Dec 2010
Term ends: Not estimatedThe source records don’t support an estimate.

Classification24 codes

A61K 35/76
Microorganisms or materials therefrom: viruses; Subviral particles; Bacteriophages
A61P 1/16
Drugs for disorders of the alimentary tract or the digestive system: for liver or gallbladder disorders, e.g. hepatoprotective agents,…
A61P 31/12
Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics: antivirals
A61P 31/14
Antivirals: for RNA viruses

Family

Application10/514,761Continuation · filed 16 Nov 2004
Application12/468,127Continuation
US 2005/0244428 A1Published application
US 7,550,147 B2Related patent
US 8,034,354 B2Related patent
US 2010/0303856 A1This patent

From the US filing history. Foreign family members aren’t listed.

Timeline

Citations

Open elsewhere

Building an agent or pulling many patents? Use the API or MCP server instead of scraping pages. Get an API key

patentgrep

Loading patent…

patentgrepSearch patents

Back to results